| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sensei Biotherapeutics, Inc. (SNSE) has 9 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. SNSE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 1.24M | $29.00M | - | |
| ? | 155.6K | $3.64M | - | |
| Other | 80.0K | $1.87M | - | |
| Dir | 23.1K | $540.5K | - | |
| Dir | 19.0K | $444.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2021 | Peyer James | Director, 10% Owner | Buy | 1,127 | $4.85 | $5,465.95 | - | -58.2% | -73.2% | |
| Dec 29, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 69,000 | $4.98 | $343,620.00 | +1.4% | -54.2% | -70.3% | |
| Dec 29, 2021 | Peyer James | Director, 10% Owner | Buy | 69,000 | $4.98 | $343,620.00 | +1.4% | -54.2% | -70.3% | |
| Dec 28, 2021 | Peyer James | Director, 10% Owner | Buy | 11,288 | $5.28 | $59,600.64 | +0.2% | -57.8% | -73.7% | |
| Dec 28, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 11,288 | $5.28 | $59,600.64 | +0.2% | -57.8% | -73.7% | |
| Dec 27, 2021 | Peyer James | Director, 10% Owner | Buy | 3,712 | $5.30 | $19,673.60 | - | -58.4% | -74.6% | |
| Dec 27, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 3,712 | $5.30 | $19,673.60 | - | -58.4% | -74.6% | |
| Dec 23, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 11,000 | $5.27 | $57,970.00 | +0.2% | -57.6% | -75.3% | |
| Dec 23, 2021 | Peyer James | Director, 10% Owner | Buy | 11,000 | $5.27 | $57,970.00 | +0.2% | -57.6% | -75.3% | |
| Dec 17, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 117 | $5.29 | $618.93 | - | -56.2% | -75.9% |